Harnessing Natural Product Compounds to Target Dormancy Survival Regulator (DosR) in Latent Tuberculosis Infection (LTBI): An In Silico Strategy Against Dormancy
Dormancy occurs when <i>Mycobacterium tuberculosis</i> (Mtb) enters a non-replicating and metabolically inactive state in response to hostile environment. During this state, it is highly resistant to conventional antibiotics, which increase the urgency to develop new potential drugs agai...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Advances in Respiratory Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2543-6031/93/3/19 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|